02:24 PM EDT, 06/27/2025 (MT Newswires) -- Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index adding 0.1% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%.

The iShares Biotechnology ETF (IBB) fell 0.4%.

In sector news, the US Supreme Court overturned a lower court's ruling that had challenged the legitimacy of the US Preventive Services Task Force under the Affordable Care Act. The decision preserves a critical provision requiring insurers to cover preventive services, such as cancer screenings, at no cost to patients.

In corporate news, Eton Pharmaceuticals ( ETON ) shares rose 0.5%. The stock will be added to the broad-market Russell 3000 and small-cap Russell 2000 after the US market closes Friday.

Sen. Maggie Hassan (D-N.H.) said she is opening an investigation into GSK's (GSK) decision to discontinue a widely used asthma inhaler for children, Reuters reported, citing a letter sent by the senator to the company. GSK shares were down 0.2%.

BioCryst Pharmaceuticals ( BCRX ) shares were down 4.3% after the company said it has agreed to sell its European Orladeyo business to Neopharmed Gentili for up to $264 million.